Table 3 Mean effectiveness outcomes by group over 12 months
Outcomes at 12 month follow-up | Intervention group | Control group | Significance* | |
|---|---|---|---|---|
Mean (SD) | Mean (SD) | p | ||
**EQ5D score (0-1) | 0.64 (0.32) n=395 | 0.61 (0.32) n=391 | 0.09 | |
Exercise per week | 305.96 min (386.5) n=298 | 305.8 min (393.3) n=279 | 0.7 | |
Adherence | ||||
Did not attend | 30 (8%) | |||
Attended <16 wks | 123 (32%) | |||
Attended 16 wks | 247 (62%) | |||
Level of adherence to NERS by variable | Did not attend | 0-16 week | Completed | |
N (%) | N %) | N (%) | ||
Referral type | CHD risk | 20 (7) | 84 (27) | 203 (66) |
MH | 0 | 4 (31) | 9 (69) | |
Both | 10 (12) | 35 (44) | 35 (44) | |
Gender | Male | 15 (11) | 31 (33) | 89 (66) |
Female | 15 (5) | 92 (35) | 158 (60) | |
Age | <44 | 5 (7) | 25 (36) | 39 (57) |
45-59 | 10 (7) | 50 (27) | 75 (56) | |
>60 | 15 (8) | 48 (24) | 133 (68) | |
WIMD | Low | 7 (5) | 49 (35) | 84 (60) |
Medium | 13 (10) | 37 (28) | 84 (63) | |
High | 9 (8) | 29 (26) | 73 (66) | |